GHK-Cu injection: protocol, dosage, and reconstitution guide.

Everything about GHK-Cu peptide injection — the fastest-growing injectable peptide keyword cluster at +9,900% year-over-year. Reconstitution math for standard 50 mg vials, optimal injection sites for anti-aging vs hair vs localized repair, cycle design, and how GHK-Cu peptide therapy protocols work under physician supervision.

GHK-Cu injection dosage chart

GHK-Cu injection dosage varies by application, target tissue, and administration method. The following dosage chart reflects protocols used in clinical peptide therapy practice prior to the Category 2 restriction, scaled from Dr. Loren Pickart's published research on the copper tripeptide.

Reconstituting GHK-Cu: the 50 mg vial

GHK-Cu arrives from compounding pharmacies as a lyophilized powder, most commonly in 50 mg vials. Reconstituting GHK-Cu 50 mg requires careful bacteriostatic water measurement to achieve accurate dosing. Here is the math:

When reconstituting GHK-Cu 50 mg, the 5 mL volume is recommended for easier measurement — each 10 units on a standard insulin syringe delivers exactly 1 mg. Inject bacteriostatic water slowly along the vial wall, never directly onto the lyophilized cake. Roll gently between palms until the solution is perfectly clear. The reconstituted solution should have a faint blue-green tint from the copper — if it appears brown or cloudy, discard and use a fresh vial. Store at 2–8°C and use within 28 days.

GHK-Cu injection site selection

GHK-Cu injection site choice depends on your treatment goal. Unlike some peptides where any subcutaneous site works equally, GHK-Cu peptide injection benefits from strategic site selection:

• Abdominal subcutaneous — standard GHK-Cu injection site for systemic anti-aging and general collagen upregulation. Pinch skin two inches from the navel, inject at 45 degrees into the fat layer. Rotate between left and right sides.
• Periorbital / facial subcutaneous — some practitioners prescribe GHK-Cu injection near facial treatment areas for targeted dermal collagen stimulation. This is an advanced technique performed under physician guidance, not self-administered.
• Scalp intradermal (mesotherapy) — for hair restoration, GHK-Cu is injected intradermally across the scalp in a grid pattern at 1 cm intervals. This delivers the peptide directly to the dermal papilla cells that regulate hair follicle cycling. Scalp mesotherapy is performed in-clinic, typically as a series of weekly sessions over 8–12 weeks.
• Localized subcutaneous — for tendon, joint, or wound healing applications, GHK-Cu injection near the target tissue delivers higher local concentrations. This approach is most relevant when stacking GHK-Cu with BPC-157 for connective tissue repair.

GHK-Cu cycle design and protocol

A standard GHK-Cu cycle runs 8–12 weeks in most clinical protocols. The rationale for this cycle length is rooted in collagen biology — type I and type III collagen synthesis requires sustained signaling over weeks to produce measurable structural changes in the dermis and connective tissue. Shorter cycles of 4–6 weeks may show initial improvements in skin hydration and tone but typically insufficient time for the deeper collagen remodeling that drives long-term anti-aging results.

GHK-Cu protocol design typically follows a consistent daily dosing approach rather than a loading/maintenance structure. Unlike growth hormone secretagogues, GHK-Cu does not appear to cause significant receptor desensitization, and some practitioners prescribe continuous protocols for extended anti-aging programs. However, most physicians recommend a 4-week break between GHK-Cu cycles as a precautionary measure and to allow assessment of cumulative copper levels through lab work.

For hair restoration via scalp mesotherapy, the GHK-Cu cycle is structured differently: weekly in-clinic sessions for 8–12 weeks as a treatment course, followed by monthly maintenance sessions. Home subcutaneous injection between sessions may be prescribed to maintain systemic peptide levels.

GHK-Cu peptide therapy: the clinical framework

GHK-Cu peptide therapy is the clinical term for physician-supervised injectable copper peptide treatment. Unlike over-the-counter topical copper peptide serums, GHK-Cu peptide therapy involves a medical evaluation, prescription, pharmaceutical-grade compounded peptide, and ongoing monitoring. The therapy framework typically includes an initial telehealth or in-person consultation, baseline lab work (comprehensive metabolic panel, serum copper, ceruloplasmin), prescription to a licensed compounding pharmacy, and follow-up assessments every 4–6 weeks during the treatment course.

GHK-Cu peptide therapy is distinct from topical copper peptide skincare in three critical ways: the delivery route bypasses the skin barrier entirely, the dosing is pharmaceutical rather than cosmetic-grade, and the treatment is supervised by a physician who monitors copper levels and clinical response. This is the pathway that will reopen when Category 1 reclassification is finalized.